(NMR) Nomura Holdings - Ratings and Ratios
Exchange: NYSE • Country: Japan • Currency: USD • Type: Common Stock • ISIN: US65535H2085
NMR: Investment, Management, Securities, Trading, Financing, Advisory
Nomura Holdings Inc ADR (NYSE:NMR) is a global financial powerhouse with a rich history dating back to 1925. Headquartered in Tokyo, Japan, Nomura operates as a full-service financial institution, catering to a diverse clientele that includes individuals, corporations, financial institutions, governments, and governmental agencies. The company is listed on the NYSE under the ticker symbol NMR and falls under the GICS Sub Industry of Investment Banking & Brokerage.
Nomura’s business is organized into three core segments: Wealth Management, Investment Management, and Wholesale. The Wealth Management division provides tailored financial products and investment consultation services, designed to meet the unique needs of high-net-worth individuals and other affluent clients. The Investment Management segment focuses on managing investment trusts, offering discretionary investment services, and operating investment funds, leveraging Nomura’s deep expertise in global markets to deliver value to its clients.
The Wholesale segment is the backbone of Nomura’s operations, engaging in a wide array of activities such as the sale, trading, and market-making of fixed income and equity products. This segment also specializes in structured finance solutions, underwriting various securities, and arranging private placements. Additionally, Nomura provides financial advisory services on complex business transactions, including mergers and acquisitions, corporate restructuring, and leveraged buyouts, positioning itself as a trusted partner for corporations navigating intricate financial landscapes.
With a market capitalization of $20.249 billion, Nomura is a significant player in the global financial services industry. The company’s current P/E ratio of 9.67 and forward P/E of 16.08 reflect its strong earnings performance and future growth expectations. The price-to-book (P/B) ratio of 0.85 indicates that the company’s stock may be undervalued relative to its book value, making it an attractive proposition for value investors. The price-to-sales (P/S) ratio of 0.01 highlights Nomura’s ability to generate revenue efficiently, a critical metric for investors evaluating the company’s operational performance.
Nomura’s global network and extensive experience in both developed and emerging markets make it a key player in cross-border transactions. Its commitment to innovation and digital transformation has enabled the company to stay ahead of the curve in a rapidly evolving financial landscape. For investors and fund managers, Nomura’s diversified business model, strong market position, and track record of resilience through economic cycles make it a compelling investment opportunity in the financial services sector.
Additional Sources for NMR Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NMR Stock Overview
Market Cap in USD | 20,046m |
Sector | Financial Services |
Industry | Capital Markets |
GiC Sub-Industry | Investment Banking & Brokerage |
IPO / Inception | 1961-10-01 |
NMR Stock Ratings
Growth 5y | 24.9% |
Fundamental | - |
Dividend | 4.35% |
Rel. Strength Industry | -10.5 |
Analysts | 3/5 |
Fair Price Momentum | 6.23 USD |
Fair Price DCF | - |
NMR Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 71.7% |
NMR Growth Ratios
Growth Correlation 3m | 52.9% |
Growth Correlation 12m | -4.4% |
Growth Correlation 5y | 31.7% |
CAGR 5y | 8.84% |
CAGR/Max DD 5y | 0.17 |
Sharpe Ratio 12m | 0.44 |
Alpha | -14.92 |
Beta | 1.60 |
Volatility | 27.53% |
Current Volume | 336.3k |
Average Volume 20d | 612k |
As of February 23, 2025, the stock is trading at USD 6.48 with a total of 336,283 shares traded.
Over the past week, the price has changed by -4.14%, over one month by +5.88%, over three months by +7.11% and over the past year by +16.34%.
Neither. Based on ValueRay Analyses, Nomura Holdings is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 24.86 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NMR as of February 2025 is 6.23. This means that NMR is currently overvalued and has a potential downside of -3.86%.
Nomura Holdings has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold NMR.
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, NMR Nomura Holdings will be worth about 6.7 in February 2026. The stock is currently trading at 6.48. This means that the stock has a potential upside of +3.86%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 7.2 | 10.8% |
Analysts Target Price | 6.2 | -4.3% |
ValueRay Target Price | 6.7 | 3.9% |